The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

There is a lot of conversation in New York about public safety and the connection to those who face mental health and ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Journavx (suzetrigine), a non-opioid pill for moderate-to-severe acute pain, has just received FDA approval. It’s the first drug in a new family of medicines that block pain signals before they ...

It is expensive, with a list price of $15.50 per pill. But unlike opioid pain medicines, it cannot become addictive. That is because the drug, suzetrigine, made by Vertex Pharmaceuticals and to be ...

The oral drug, branded Journavx, works by blocking pain signals at their source, unlike opioids — which trigger the brain's reward centers as they travel through the blood and then attach to ...

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

An estimated 2.5 million American adults have an addiction to opioids, which were responsible for more than 107,000 fatal overdoses in 2023. Next in the study, published in the journal Drug ...

The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to treat moderate-to-severe acute ...